| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |